Atopic Dermatitis Research Study (Topical)

Adults aged 18 years or older with eczema (atopic dermatitis) lasting for at least 2 years, may qualify to participate. Individuals must have mild to moderate disease, involving 3%-20% of their body surface area, with at least 1 target lesion. Discontinuation of all medications used to treat eczema (atopic dermatitis), is required during the course of the study.

Participants will receive investigational cream (active study drug) or placebo during the vehicle-controlled period. During the long-term safety extension period, those individuals who previously received placebo will receive active study drug. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 60 weeks and involve about 17 visits to the study centre.

 Call the study centre near you or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more